Out of Munich, Germany, Ingenium Pharmaceuticals AG have delighted themselves with the news of the publication of in "A Mouse Model for Cystinuria Type I" in the September issue of Human Molecular Genetics. The article, with as many authors as a whore gets clients in a day, represents the first mouse model of cystinuria type I, otherwise known as kidney stones.
The mouse represents research from Ingenium's Deductive Genomics program and is expected to aid in the research for therapeutic solutions to the disease. "The goal of our research is to better understand the molecular pathway involved with cystinuria type I and this model is a welcome addition because it is the first model that so closely mimics the human disease state," stated Dr. Thomas Knoll, noted specialist in urology research at the University Hospital Mannheim.
In a separate yet related event, an agreement was struck between Ingenium and the Department of Urology at the University Hospital Mannheim to allow the Department of Urology access to the proprietary INGENOtypes mouse model. The mouse models are seen as critical tools in the continued experimentation on rodents for the purposes of biomedical research and therapeutic hypotheses.
Written on Wednesday, 3 September 2003